Cargando…

Timelines to initiate a phase III trial across the globe: a sub-analysis of the APHINITY trial

BACKGROUND: Geographic location and national income may influence access to innovation in healthcare. We aimed to study if geographical location and national income influenced the timelines to activate the global phase III APHINITY trial, evaluating adjuvant pertuzumab in patients with HER2-positive...

Descripción completa

Detalles Bibliográficos
Autores principales:	Franzoi, Maria Alice, Procter, Marion, Twelves, Chris, Ponde, Noam, Eiger, Daniel, Emond, Orianne, Clark, Emma, Parlier, Damien, Guillaume, Sébastien, Reaby, Linda, de Azambuja, Evandro, Bines, Jose
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cancer Intelligence 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9116999/ https://www.ncbi.nlm.nih.gov/pubmed/35702414 http://dx.doi.org/10.3332/ecancer.2022.1379

Ejemplares similares

Cardiac safety of dual anti-HER2 blockade with pertuzumab plus trastuzumab in early HER2-positive breast cancer in the APHINITY trial
por: de Azambuja, E., et al.
Publicado: (2023)

Cardiotoxicity of trastuzumab given for 12 months compared to shorter treatment periods: a systematic review and meta-analysis of six clinical trials
por: Eiger, Daniel, et al.
Publicado: (2020)

Pharmacokinetic and exploratory exposure–response analysis of pertuzumab in patients with operable HER2-positive early breast cancer in the APHINITY study
por: Kirschbrown, Whitney P., et al.
Publicado: (2019)

Atezolizumab in metastatic triple-negative breast cancer: IMpassion130 and 131 trials - how to explain different results?
por: Franzoi, Maria Alice, et al.
Publicado: (2020)

Phosphoethanolamine and the danger of unproven drugs
por: Pondé, Noam, et al.
Publicado: (2016)

Threat posed by unproven drugs in medical oncology
por: Pondé, Noam, et al.
Publicado: (2016)

Clinical outcomes of platinum-based chemotherapy in patients with advanced breast cancer: An 11-year single institutional experience
por: Franzoi, Maria Alice, et al.
Publicado: (2021)

Twenty years of anti-HER2 therapy-associated cardiotoxicity
por: Pondé, Noam F, et al.
Publicado: (2016)

Lessons learned at SABCS 2019 and to-dos from immunotherapy in breast cancer
por: Eiger, Daniel, et al.
Publicado: (2020)

Long-term cardiac outcomes of patients with HER2-positive breast cancer treated in the adjuvant lapatinib and/or trastuzumab Treatment Optimization Trial
por: Eiger, Daniel, et al.
Publicado: (2020)

Post-neoadjuvant treatment and the management of residual disease in breast cancer: state of the art and perspectives
por: Caparica, Rafael, et al.
Publicado: (2019)

The Exciting New Field of HER2-Low Breast Cancer Treatment
por: Eiger, Daniel, et al.
Publicado: (2021)

Online timeline
por: Carlson, David
Publicado: (2005)

Decade timeline
Publicado: (2009)

Timeline: Vaccines
por: Rappuoli, Rino
Publicado: (2020)

Investigational Research: Timeline, Trials, and Future Directions of Spinal Disc Arthroplasty
por: Fiani, Brian, et al.
Publicado: (2021)

Impact of Age on Clinical Outcomes and Efficacy of Adjuvant Dual Anti-HER2 Targeted Therapy
por: Lambertini, Matteo, et al.
Publicado: (2022)

CLIC project timeline
por: CLIC, Compact Linear Collider Project
Publicado: (2018)

Physics Timeline Poster
por: Davis, Siona Ruth
Publicado: (03-0)

Timeline for the Strategy Update
Publicado: (2011)

Timeline for the Strategy Update
Publicado: (2011)

History of Medicine Timeline
por: Hajar, Rachel
Publicado: (2015)

A timeline for exocytosis
por: Short, Ben
Publicado: (2015)

Stem Cell Timeline
Publicado: (2015)

Metrological Timelines in Traceability
por: Ehrlich, Charles D., et al.
Publicado: (1998)

Health timeline: an insight-based study of a timeline visualization of clinical data
por: Ledesma, Andres, et al.
Publicado: (2019)

Endocrine therapy-based treatments in hormone receptor-positive/HER2-negative advanced breast cancer: systematic review and network meta-analysis
por: Brandão, Mariana, et al.
Publicado: (2020)

Timeline for Particle Collider in doubt
por: Klapper, Bradley S
Publicado: (2007)

Timeline for particle collider in doubt
por: Klapper, Bradley S
Publicado: (2007)

5YR 2021 Timelines
por: Cook, Anna
Publicado: (2019)

Timeline of History of Hypertension Treatment
por: Saklayen, Mohammad G., et al.
Publicado: (2016)

Wandering along the epigenetic timeline
por: Topart, Clémence, et al.
Publicado: (2020)

Timelines of COVID-19 vaccines
por: Chugh, Tulsi
Publicado: (2020)

A single center analysis of factors influencing study start-up timeline in clinical trials
por: Krafcik, Brianna M, et al.
Publicado: (2017)

140 Feasibility of Implementing Community Engaged Recruitment Approaches into a Multisite Trial with an Accelerated Timeline
por: Pressley, Megan, et al.
Publicado: (2022)

Prognostic role of distant disease-free interval from completion of adjuvant trastuzumab in HER2-positive early breast cancer: analysis from the ALTTO (BIG 2-06) trial
por: Lambertini, Matteo, et al.
Publicado: (2020)

Biomarkers of response and resistance to PI3K inhibitors in estrogen receptor-positive breast cancer patients and combination therapies involving PI3K inhibitors
por: Brandão, M, et al.
Publicado: (2019)

Are we HER-ting for innovation in neoadjuvant breast cancer trial design?
por: Snoj, Natasa, et al.
Publicado: (2009)

Globe
por: Balle, Ch
Publicado: (2012)

The Globe
por: Bennett, Sophia Elizabeth
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_snk08ivjor5d7kq79m1qq5hp65